235 related articles for article (PubMed ID: 26988910)
1. MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.
Rossi M; Colecchia D; Ilardi G; Acunzo M; Nigita G; Sasdelli F; Celetti A; Strambi A; Staibano S; Croce CM; Chiariello M
Oncotarget; 2016 Apr; 7(15):20981-98. PubMed ID: 26988910
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
3. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
4. MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation.
Colecchia D; Rossi M; Sasdelli F; Sanzone S; Strambi A; Chiariello M
Autophagy; 2015; 11(10):1790-802. PubMed ID: 26291129
[TBL] [Abstract][Full Text] [Related]
5. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
6. Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.
Romano FJ; Rossetti S; Conteduca V; Schepisi G; Cavaliere C; Di Franco R; La Mantia E; Castaldo L; Nocerino F; Ametrano G; Cappuccio F; Malzone G; Montanari M; Vanacore D; Quagliariello V; Piscitelli R; Pepe MF; Berretta M; D'Aniello C; Perdonà S; Muto P; Botti G; Ciliberto G; Veneziani BM; De Falco F; Maiolino P; Caraglia M; Montella M; De Giorgi U; Facchini G
Oncotarget; 2016 Dec; 7(51):85641-85649. PubMed ID: 27821802
[TBL] [Abstract][Full Text] [Related]
7. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456
[TBL] [Abstract][Full Text] [Related]
8. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract][Full Text] [Related]
10. MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins.
Colecchia D; Strambi A; Sanzone S; Iavarone C; Rossi M; Dall'Armi C; Piccioni F; Verrotti di Pianella A; Chiariello M
Autophagy; 2012 Dec; 8(12):1724-40. PubMed ID: 22948227
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human mitogen-activated protein kinase 15 (extracellular signal-regulated kinase 7/8) and its functions: A recent update.
Lau ATY; Xu YM
J Cell Physiol; 2018 Jan; 234(1):75-88. PubMed ID: 30070699
[TBL] [Abstract][Full Text] [Related]
12. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
Cavallo F; Feldman DR; Barchi M
Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
[TBL] [Abstract][Full Text] [Related]
13. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.
Kerley-Hamilton JS; Pike AM; Li N; DiRenzo J; Spinella MJ
Oncogene; 2005 Sep; 24(40):6090-100. PubMed ID: 15940259
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin resistance in germ cell tumours: models and mechanisms.
Jacobsen C; Honecker F
Andrology; 2015 Jan; 3(1):111-21. PubMed ID: 25546083
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
19. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
[TBL] [Abstract][Full Text] [Related]
20. A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells.
Lutzker SG; Mathew R; Taller DR
Oncogene; 2001 May; 20(23):2982-6. PubMed ID: 11420711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]